J Neurovirol. 2003 Aug;9(4):421-31.

Development of a recombinant vaccine against Japanese encephalitis.

Source

National Institute of Immunology, Aruna Asaf Ali Marg, New Delhi, India.

Abstract

Japanese encephalitis (JE) is the major form of viral encephalitis in much of the South-East Asia, India, and China. The disease is caused by a mosquito-borne virus known as Japanese encephalitis virus (JEV). The virus spreads in the form of epidemics, although several endemic areas for JEV activity are known. In recent years, JEV has spread to newer geographic locations such as Australia and Pakistan, and thus has become an important emerging virus infection in these areas. A mouse brain-derived, formalin-inactivated vaccine is available for immunization against JE. Because the formalin-inactivated JEV vaccine has limitations in terms of safety, availability, and cost, attempts are being made to develop improved vaccine using the recombinant DNA technology. This article reviews various attempts in this direction and summarizes the latest developments such as the recombinant yellow fever virus- or the plasmid DNA-based JEV vaccine.

PMID:: 12907387; [PubMed - indexed for MEDLINE]

Publication Types, MeSH Terms, Substances

Publication Types

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Supplemental Content

Save items

Related citations in PubMed

Review IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine. [Expert Rev Vaccines. 2010]
Review IMOJEV(®): a Yellow fever virus-based novel Japanese encephalitis vaccine.
Appaiahgari MB, Vrati S. Expert Rev Vaccines. 2010 Dec; 9(12):1371-84.
Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine. [Vaccine. 2003]
Induction of cross-protection against two wild-type Taiwanese isolates of Japanese encephalitis virus using Beijing-1 strain DNA vaccine.
Wu CJ, Huang HW, Tao MH. Vaccine. 2003 Sep 8; 21(25-26):3938-45.
Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP). [MMWR Recomm Rep. 2010]
Japanese encephalitis vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP).
Fischer M, Lindsey N, Staples JE, Hills S, Centers for Disease Control and Prevention (CDC). MMWR Recomm Rep. 2010 Mar 12; 59(RR-1):1-27.
Review New Japanese encephalitis vaccines: alternatives to production in mouse brain. [Expert Rev Vaccines. 2011]
Review New Japanese encephalitis vaccines: alternatives to production in mouse brain.
Halstead SB, Thomas SJ. Expert Rev Vaccines. 2011 Mar; 10(3):355-64.
Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice. [J Gene Med. 2009]
Immunization with pseudotype baculovirus expressing envelope protein of Japanese encephalitis virus elicits protective immunity in mice.
Li Y, Ye J, Cao S, Xiao S, Zhao Q, Liu X, Jin M, Chen H. J Gene Med. 2009 Feb; 11(2):150-9.

See reviews... See all...

Cited by 6 PubMed Central articles

Fenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infection. [PLoS One. 2012]
Fenofibrate reduces mortality and precludes neurological deficits in survivors in murine model of Japanese encephalitis viral infection.
Sehgal N, Kumawat KL, Basu A, Ravindranath V. PLoS One. 2012; 7(4):e35427. Epub 2012 Apr 13.
Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice. [Virol J. 2011]
Design and evaluation of a multi-epitope assembly peptide (MEAP) against herpes simplex virus type 2 infection in BALB/c mice.
Wang X, Xie G, Liao J, Yin D, Guan W, Pan M, Li J, Li Y. Virol J. 2011 May 16; 8:232. Epub 2011 May 16.
Mutation of putative N-linked glycosylation sites in Japanese encephalitis virus premembrane and envelope proteins enhances humoral immunity in BALB/C mice after DNA vaccination. [Virol J. 2011]
Mutation of putative N-linked glycosylation sites in Japanese encephalitis virus premembrane and envelope proteins enhances humoral immunity in BALB/C mice after DNA vaccination.
Zhang Y, Chen P, Cao R, Gu J. Virol J. 2011 Mar 25; 8:138. Epub 2011 Mar 25.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Development of a recombinant vaccine against Japanese encephalitis.
Development of a recombinant vaccine against Japanese encephalitis.
J Neurovirol. 2003 Aug ;9(4):421-31.

PubMed
Intestinal cytokines in children with pervasive developmental disorders.
Intestinal cytokines in children with pervasive developmental disorders.
Am J Gastroenterol. 2003 Aug ;98(8):1777-82.

PubMed
Purkinje cell vulnerability and autism: a possible etiological connection.
Purkinje cell vulnerability and autism: a possible etiological connection.
Brain Dev. 2003 Sep ;25(6):377-82.

PubMed
Decline in fish consumption among pregnant women after a national mercury adviso...
Decline in fish consumption among pregnant women after a national mercury advisory.
Obstet Gynecol. 2003 Aug ;102(2):346-51.

PubMed
Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American I...
Efficacy and safety of seven-valent conjugate pneumococcal vaccine in American Indian children: group randomised trial.
Lancet. 2003 Aug 2 ;362(9381):355-61.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to: